Previous research indicated that SIRT1 activates chemoresistance in leukemia by deacetylating p53 in AML and p53, Ku70, Foxo1, and Hsp90 in CML (20). This evidence concerns the gene XRCC6 and chronic myelogenous leukemia, BCR-ABL1 positive.